Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis

Timothy Guilford1, Devin Morris, Dennis Gray

  • 1Your Energy Systems, Palo Alto, CA, USA.

HIV/AIDS (Auckland, N.Z.)
|November 19, 2011
PubMed

Insights

Oxidized LDL impairs macrophage function, increasing susceptibility to Mycobacterium tuberculosis infection in individuals with atherosclerosis, especially those with HIV. This highlights a critical link between cardiovascular disease and infectious disease risk.

Area of Science:

  • Immunology
  • Cardiovascular Disease
  • Infectious Disease

Background:

  • Atherosclerosis, a major cause of heart disease and stroke, is linked to increased risk in HIV-infected individuals.
  • Human Immunodeficiency Virus (HIV) damages CD4+ T cells, impairing immune function and increasing susceptibility to opportunistic infections like tuberculosis.
  • Acquired Immunodeficiency Syndrome (AIDS) is a significant public health concern in the US, with over 1 million Americans potentially infected with HIV.

Purpose of the Study:

  • To review the impact of oxidized low-density lipoproteins (oxLDL) on macrophage function.
  • To examine how oxLDL-impaired macrophages influence susceptibility to Mycobacterium tuberculosis infection.
  • To compare these effects in individuals with atherosclerosis, with and without HIV infection.

Main Methods:

  • Literature review summarizing existing research on oxLDL, macrophage function, and Mycobacterium tuberculosis.
  • Analysis of studies investigating the interplay between HIV, atherosclerosis, and immune response.
  • Synthesis of findings related to cellular mechanisms and disease susceptibility.

Main Results:

  • Oxidized low-density lipoproteins impair macrophage functions critical for combating infections.
  • This impairment is exacerbated in individuals with atherosclerosis, particularly those co-infected with HIV.
  • Compromised macrophage function enhances susceptibility to Mycobacterium tuberculosis infection.

Conclusions:

  • Oxidized LDL plays a key role in macrophage dysfunction within the context of atherosclerosis and HIV.
  • This dysfunction increases the risk and severity of Mycobacterium tuberculosis infections in vulnerable populations.
  • Understanding these mechanisms is crucial for developing targeted therapeutic strategies.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...